Diagnostic Imaging

Radiologists use diagnostic imaging to non-invasively look inside the body to help determine the causes of an injury or an illness, and confirm a diagnosis. Providers use many imaging modalities to do so, including CT, MRI, X-ray, Ultrasound, PET and more.

Simple measurement from routine X-rays accurately predicts post-op lung cancer outcomes
For the first time, research has identified diaphragmatic dome height measured on chest X-rays as an indicator of what patients’ post-op recovery will look like following surgery for cancer or other lung disorders.
High-sensitivity troponin protocol most successful at freestanding EDs
Freestanding EDs demonstrated meaningful operational advantages over hospitals when using an accelerated troponin pathway. This included earlier discharges for low-risk chest pain patients.
FDA clears Qure.ai's CAD tool for chest X-rays
The product is used to highlight findings from plain chest radiographs completed in emergency departments, urgent care clinics and family practices.
Cardiologist discusses Lp(a), the CVD risk factor responsible for many surprise heart attacks
Cardiologist Nathaniel Lebowitz, MD, reviews the latest updates in lipoprotein(a) awareness, testing and drug development.
Siemens Healthineers' partnership sets sights on point-of-care testing for athletes
On-the-field imaging helps determine if athletes can be treated effectively on-site or whether they might need to be transferred to a medical center for additional care.

Diaphragmatic dome height could inform lung cancer surgery outcomes

Simple measurement from routine X-rays accurately predicts post-op lung cancer outcomes

For the first time, research has identified diaphragmatic dome height measured on chest X-rays as an indicator of what patients’ post-op recovery will look like following surgery for cancer or other lung disorders.

High-sensitivity troponin protocol most successful at freestanding EDs

Freestanding EDs demonstrated meaningful operational advantages over hospitals when using an accelerated troponin pathway. This included earlier discharges for low-risk chest pain patients.

Qure.ai CAD chest X-ray reporting tool cleared by FDA

FDA clears Qure.ai's CAD tool for chest X-rays

The product is used to highlight findings from plain chest radiographs completed in emergency departments, urgent care clinics and family practices.

Nathaniel Lebowitz, MD, in charge of preventive cardiology at Hackensack University Medical Center, and assistant professor of internal medicine at Hackensack Meridian School of Medicine, gives an overview of where things are at with lipoprotein (a) awareness, testing and drug development. He and is working on the American Heart Associations (AHA) Lp(a) Discovery Project to expand awareness to both physicians and patients. #AHA #LPA

Cardiologist discusses Lp(a), the CVD risk factor responsible for many surprise heart attacks

Cardiologist Nathaniel Lebowitz, MD, reviews the latest updates in lipoprotein(a) awareness, testing and drug development.

Siemens Healthineers' partnership sets sights on point-of-care testing for athletes

On-the-field imaging helps determine if athletes can be treated effectively on-site or whether they might need to be transferred to a medical center for additional care.

Chest radiograph in a 53-year-old woman with confirmed coronavirus disease 2019, or COVID-19, pneumonia. The patient had fever and cough for 5 days. Multifocal patchy opacities (arrows) can be seen in both lungs. Image courtesy of RSNA. What COVID looks like ob CT medical imaging.

Current imaging AI systems can be repurposed to address future pandemics, study asserts

Experts say these new findings represent “a significant advancement in the field of radiology."

Dynamic chest radiography could be an alternative to pulmonary function tests for diagnosing COPD

Dynamic chest radiography could potentially replace pulmonary function tests

The X-ray technique uses continuous radiographic acquisition during respiration to assess lung function.

Community Health Systems sells ambulatory diagnostics segment to Labcorp for $194M

The all-cash deal is expected to be finalized in April 2026. With this divestment of its ambulatory labs, Tennessee-based Community Health Systems said it will be better able to focus on its core patient care business.